These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22104208)

  • 1. Mutations in the HIV-1 reverse transcriptase tryptophan repeat motif affect virion maturation and Gag-Pol packaging.
    Chiang CC; Tseng YT; Huang KJ; Pan YY; Wang CT
    Virology; 2012 Jan; 422(2):278-87. PubMed ID: 22104208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations at human immunodeficiency virus type 1 reverse transcriptase tryptophan repeat motif attenuate the inhibitory effect of efavirenz on virus production.
    Chiang CC; Wang SM; Tseng YT; Huang KJ; Wang CT
    Virology; 2009 Jan; 383(2):261-70. PubMed ID: 19019404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of amino acid residues in HIV-1 reverse transcriptase that are critical for the proteolytic processing of Gag-Pol precursors.
    Nishitsuji H; Yokoyama M; Sato H; Yamauchi S; Takaku H
    FEBS Lett; 2011 Nov; 585(21):3372-7. PubMed ID: 22004763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single amino acid substitution in HIV-1 reverse transcriptase significantly reduces virion release.
    Chiang CC; Wang SM; Pan YY; Huang KJ; Wang CT
    J Virol; 2010 Jan; 84(2):976-82. PubMed ID: 19889767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations that abrogate human immunodeficiency virus type 1 reverse transcriptase dimerization affect maturation of the reverse transcriptase heterodimer.
    Wapling J; Moore KL; Sonza S; Mak J; Tachedjian G
    J Virol; 2005 Aug; 79(16):10247-57. PubMed ID: 16051818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 reverse transcriptase stability correlates with Gag cleavage efficiency: reverse transcriptase interaction implications for modulating protease activation.
    Hsieh SH; Yu FH; Huang KJ; Wang CT
    J Virol; 2023 Sep; 97(9):e0094823. PubMed ID: 37671867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of amino acid residues in the human immunodeficiency virus type-1 reverse transcriptase tryptophan-repeat motif that are required for subunit interaction using infectious virions.
    Mulky A; Sarafianos SG; Jia Y; Arnold E; Kappes JC
    J Mol Biol; 2005 Jun; 349(4):673-84. PubMed ID: 15893326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolytic cleavage at the Gag-Pol junction in avian leukosis virus: differences in vitro and in vivo.
    Stewart L; Vogt VM
    Virology; 1994 Oct; 204(1):45-59. PubMed ID: 7522375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of human immunodeficiency virus type 1 Pr160 gag-pol mutants with truncations downstream of the protease domain.
    Liao WH; Wang CT
    Virology; 2004 Nov; 329(1):180-8. PubMed ID: 15476885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 Mutant Assembly, Processing and Infectivity Expresses Pol Independent of Gag.
    Yu FH; Huang KJ; Wang CT
    Viruses; 2020 Jan; 12(1):. PubMed ID: 31906562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of reverse transcriptase sequences in Pol with Gag and LysRS in the HIV-1 tRNALys3 packaging/annealing complex.
    Saadatmand J; Guo F; Cen S; Niu M; Kleiman L
    Virology; 2008 Oct; 380(1):109-17. PubMed ID: 18708237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virion instability of human immunodeficiency virus type 1 reverse transcriptase (RT) mutated in the protease cleavage site between RT p51 and the RT RNase H domain.
    Abram ME; Parniak MA
    J Virol; 2005 Sep; 79(18):11952-61. PubMed ID: 16140771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cotransfection of mutated forms of human immunodeficiency virus type 1 Gag-Pol with wild-type constructs can interfere with processing and viral replication.
    Morin N; Cherry E; Li X; Wainberg MA
    J Hum Virol; 1998; 1(3):240-7. PubMed ID: 10195247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of human immunodeficiency virus type-1 (HIV-1) particles that express protease-reverse transcriptase fusion proteins.
    Cherry E; Liang C; Rong L; Quan Y; Inouye P; Li X; Morin N; Kotler M; Wainberg MA
    J Mol Biol; 1998 Nov; 284(1):43-56. PubMed ID: 9811541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the protease gene of human immunodeficiency virus type 1 affect release and stability of virus particles.
    Park J; Morrow CD
    Virology; 1993 Jun; 194(2):843-50. PubMed ID: 8503189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mutation T477A in HIV-1 reverse transcriptase (RT) restores normal proteolytic processing of RT in virus with Gag-Pol mutated in the p51-RNH cleavage site.
    Abram ME; Sarafianos SG; Parniak MA
    Retrovirology; 2010 Feb; 7():6. PubMed ID: 20122159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of HIV constructs containing protease-reverse transcriptase fusion proteins on viral replication.
    Cherry E; Morin N; Wainberg MA
    AIDS; 1998 Jun; 12(9):967-75. PubMed ID: 9662192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles.
    Karacostas V; Wolffe EJ; Nagashima K; Gonda MA; Moss B
    Virology; 1993 Apr; 193(2):661-71. PubMed ID: 7681610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolytic processing of an HIV-1 pol polyprotein precursor: insights into the mechanism of reverse transcriptase p66/p51 heterodimer formation.
    Sluis-Cremer N; Arion D; Abram ME; Parniak MA
    Int J Biochem Cell Biol; 2004 Sep; 36(9):1836-47. PubMed ID: 15183348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of the Gag-Pol transframe domain p6* and its coding sequence to morphogenesis and replication of human immunodeficiency virus type 1.
    Paulus C; Ludwig C; Wagner R
    Virology; 2004 Dec; 330(1):271-83. PubMed ID: 15527852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.